Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 1
1995 2
1996 1
1997 2
1998 7
1999 5
2000 8
2001 12
2002 11
2003 8
2004 5
2005 10
2006 7
2007 4
2008 10
2009 10
2010 12
2011 6
2012 8
2013 5
2014 11
2015 6
2016 8
2017 1
2018 3
2019 14
2020 10
2021 8
2022 5
2023 8
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 12371804

201 results

Results by year

Filters applied: . Clear all
Page 1
Oral therapies for diabetic hyperglycemia.
Lebovitz HE. Lebovitz HE. Endocrinol Metab Clin North Am. 2001 Dec;30(4):909-33. doi: 10.1016/s0889-8529(05)70221-8. Endocrinol Metab Clin North Am. 2001. PMID: 11727405 Review.
Type II diabetes mellitus.
Edelman SV. Edelman SV. Adv Intern Med. 1998;43:449-500. Adv Intern Med. 1998. PMID: 9506190 Review.
Glycemic/metabolic responses to identical meal tolerance tests at breakfast, lunch and dinner in Japanese patients with type 2 diabetes mellitus treated with a dipeptidyl peptidase-4 inhibitor and the effects of adding a mitiglinide/voglibose fixed-dose combination.
Ono Y, Kamoshima H, Nakamura A, Nomoto H. Ono Y, et al. Expert Opin Pharmacother. 2014 Sep;15(13):1785-95. doi: 10.1517/14656566.2014.939070. Epub 2014 Jul 21. Expert Opin Pharmacother. 2014. PMID: 25046055 Clinical Trial.
TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
Tsujihata Y, Ito R, Suzuki M, Harada A, Negoro N, Yasuma T, Momose Y, Takeuchi K. Tsujihata Y, et al. J Pharmacol Exp Ther. 2011 Oct;339(1):228-37. doi: 10.1124/jpet.111.183772. Epub 2011 Jul 13. J Pharmacol Exp Ther. 2011. PMID: 21752941
201 results